[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

September 2020 - July 1959

Decade

Year

Issue

July 2016, Vol 73, No. 7, Pages 645-759

In This Issue of JAMA Psychiatry

In This Issue

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):645. doi:10.1001/jamapsychiatry.2015.1636
Editorial

Joint Decision Making and Reduced Need for Compulsory Psychiatric Admission

Abstract Full Text
JAMA Psychiatry. 2016;73(7):647-648. doi:10.1001/jamapsychiatry.2016.0571

Glutamatergic Dysfunction in Schizophrenia Evaluated With Magnetic Resonance Spectroscopy

Abstract Full Text
JAMA Psychiatry. 2016;73(7):649-650. doi:10.1001/jamapsychiatry.2016.0575

What Are We Learning From Early-Phase Clinical Trials With Glutamate Targeting Medications for the Treatment of Major Depressive Disorder

Abstract Full Text
JAMA Psychiatry. 2016;73(7):651-652. doi:10.1001/jamapsychiatry.2016.0780

The Intersection of Environment and the Genome in Posttraumatic Stress Disorder

Abstract Full Text
JAMA Psychiatry. 2016;73(7):653-654. doi:10.1001/jamapsychiatry.2016.0349

Can Attention-Deficit/Hyperactivity Disorder Onset Occur in Adulthood?

Abstract Full Text
JAMA Psychiatry. 2016;73(7):655-656. doi:10.1001/jamapsychiatry.2016.0400
Original Investigation

Meta-analysis

Interventions to Reduce Compulsory Psychiatric Admissions: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):657-664. doi:10.1001/jamapsychiatry.2016.0501

This systematic review and meta-analysis establishes which interventions (advance statements, community treatment orders, compliance enhancement, or integrated treatment) effectively reduce compulsory admissions in adult psychiatric patients in outpatient settings.

Meta-analysis

Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):665-674. doi:10.1001/jamapsychiatry.2016.0442

This meta-analysis evaluates the levels of glutamate, glutamine, or the combined Glx signals determined with proton magnetic resonance spectroscopy in patients at high risk for schizophrenia as well as in those with first-episode psychosis or chronic schizophrenia.

Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):675-684. doi:10.1001/jamapsychiatry.2016.0838

This randomized clinical trial evaluates the safety and efficacy of basimglurant modified-release vs placebo as adjunctive therapy to ongoing antidepressant medication therapy in patients with major depressive disorder who had inadequate response within the current episode.

Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):685-694. doi:10.1001/jamapsychiatry.2016.0892

This randomized trial compares the efficacy of targeted complicated grief treatment, citalopram, both, or neither on the outcomes of patients with complicated grief.

Genome-wide Association Studies of Posttraumatic Stress Disorder in 2 Cohorts of US Army Soldiers

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):695-704. doi:10.1001/jamapsychiatry.2016.0350

This genome-wide association study assesses genetic loci associated with the lifetime risk for posttraumatic stress disorder in 2 cohorts of US military personnel and veterans.

Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):705-712. doi:10.1001/jamapsychiatry.2016.0383

This study investigates whether impaired young adults with attention-deficit/hyperactivity disorder symptoms always have a childhood-onset disorder in a population-based longitudinal study.

Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):713-720. doi:10.1001/jamapsychiatry.2016.0465

This study investigates childhood risk factors and functioning in young adults with persistent, remitted, and late-onset ADHD.

Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):721-730. doi:10.1001/jamapsychiatry.2016.0538

This observational study examines the use of glucose and lipid testing in Medicaid patients receiving antipsychotic therapy.

Associations Between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis vs Tobacco Users

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):731-740. doi:10.1001/jamapsychiatry.2016.0637

This 38-year longitudinal study of a representative birth cohort (the Dunedin Multidisciplinary Health and Development Study of New Zealand) tests associations between cannabis use over 20 years and a variety of physical health indexes at early midlife.

Risk Factors, Methods, and Timing of Suicide Attempts Among US Army Soldiers

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):741-749. doi:10.1001/jamapsychiatry.2016.0600

This longitudinal cohort study examines suicide attempt risk factors, methods, and timing among soldiers currently deployed, previously deployed, and never deployed.

Special Communication

Unintended Consequences of Changing the Definition of Posttraumatic Stress Disorder in DSM-5: Critique and Call for Action

Abstract Full Text
JAMA Psychiatry. 2016;73(7):750-752. doi:10.1001/jamapsychiatry.2016.0647

This Special Communication argues against changing the definition of posttraumatic stress disorder in DSM-5.

Correcting Misconceptions About the Diagnostic Criteria for Posttraumatic Stress Disorder in DSM-5

Abstract Full Text
JAMA Psychiatry. 2016;73(7):753-754. doi:10.1001/jamapsychiatry.2016.0745

This Special Communication argues for changing the definition of posttraumatic stress disorder in DSM-5.

Comment & Response

Treatment Options for Veterans With Posttraumatic Stress Disorder

Abstract Full Text
JAMA Psychiatry. 2016;73(7):756. doi:10.1001/jamapsychiatry.2016.0563

Treatment Options for Veterans With Posttraumatic Stress Disorder

Abstract Full Text
JAMA Psychiatry. 2016;73(7):756-757. doi:10.1001/jamapsychiatry.2016.0746

Treatment Options for Veterans With Posttraumatic Stress Disorder—Reply

Abstract Full Text
JAMA Psychiatry. 2016;73(7):757-758. doi:10.1001/jamapsychiatry.2016.0573

Treatment Options for Veterans With Posttraumatic Stress Disorder—Reply

Abstract Full Text
JAMA Psychiatry. 2016;73(7):758. doi:10.1001/jamapsychiatry.2016.0572

Errors in Identification of 17 of 527 Brain Images in Genetic Study of Phenotypes Associated With Bipolar Disorder

Abstract Full Text
JAMA Psychiatry. 2016;73(7):758-759. doi:10.1001/jamapsychiatry.2016.1051
Correction

Errors in Data

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):759. doi:10.1001/jamapsychiatry.2016.1117
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(7):646. doi:10.1001/jamapsychiatry.2015.1637
×